ChromaVision Test for Breast-Cancer Spread
- Share via
Dow Jones
ChromaVision Medical Systems Inc. in San Juan Capistrano unveiled a test Monday to assist in detecting the spread of cancer outside the breast, a condition that frequently is not found in routine tests.
The company said its Automated Cellular Imaging System test will initially be applied to lymph-node evaluation in breast cancer, but has wider applications.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
